Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1611248559;48560;48561 chr2:178615767;178615766;178615765chr2:179480494;179480493;179480492
N2AB1447143636;43637;43638 chr2:178615767;178615766;178615765chr2:179480494;179480493;179480492
N2A1354440855;40856;40857 chr2:178615767;178615766;178615765chr2:179480494;179480493;179480492
N2B704721364;21365;21366 chr2:178615767;178615766;178615765chr2:179480494;179480493;179480492
Novex-1717221739;21740;21741 chr2:178615767;178615766;178615765chr2:179480494;179480493;179480492
Novex-2723921940;21941;21942 chr2:178615767;178615766;178615765chr2:179480494;179480493;179480492
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: L
  • RefSeq wild type transcript codon: CTA
  • RefSeq wild type template codon: GAT
  • Domain: Fn3-4
  • Domain position: 58
  • Structural Position: 89
  • Q(SASA): 0.2694
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
L/V rs747917712 -1.045 0.722 N 0.465 0.185 0.396794106654 gnomAD-2.1.1 4.04E-06 None None None None N None 0 0 None 0 0 None 0 None 0 8.92E-06 0
L/V rs747917712 -1.045 0.722 N 0.465 0.185 0.396794106654 gnomAD-4.0.0 3.42527E-06 None None None None N None 2.99796E-05 0 None 0 0 None 0 0 2.70086E-06 0 1.6597E-05

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
L/A 0.1902 likely_benign 0.2376 benign -1.893 Destabilizing 0.633 D 0.517 neutral None None None None N
L/C 0.3746 ambiguous 0.4679 ambiguous -1.051 Destabilizing 0.996 D 0.646 neutral None None None None N
L/D 0.6009 likely_pathogenic 0.6758 pathogenic -1.736 Destabilizing 0.923 D 0.669 neutral None None None None N
L/E 0.2617 likely_benign 0.3054 benign -1.586 Destabilizing 0.633 D 0.611 neutral None None None None N
L/F 0.2094 likely_benign 0.2706 benign -1.124 Destabilizing 0.987 D 0.53 neutral None None None None N
L/G 0.3738 ambiguous 0.4422 ambiguous -2.34 Highly Destabilizing 0.923 D 0.668 neutral None None None None N
L/H 0.2408 likely_benign 0.3099 benign -1.553 Destabilizing 0.979 D 0.729 prob.delet. None None None None N
L/I 0.1359 likely_benign 0.1539 benign -0.656 Destabilizing 0.84 D 0.422 neutral N 0.475417481 None None N
L/K 0.182 likely_benign 0.2235 benign -1.311 Destabilizing 0.633 D 0.565 neutral None None None None N
L/M 0.0945 likely_benign 0.1105 benign -0.534 Destabilizing 0.961 D 0.569 neutral None None None None N
L/N 0.2534 likely_benign 0.2848 benign -1.469 Destabilizing 0.923 D 0.69 prob.neutral None None None None N
L/P 0.1991 likely_benign 0.2509 benign -1.043 Destabilizing 0.949 D 0.714 prob.delet. N 0.473030558 None None N
L/Q 0.1116 likely_benign 0.1427 benign -1.447 Destabilizing 0.014 N 0.443 neutral N 0.462583315 None None N
L/R 0.1546 likely_benign 0.2071 benign -0.924 Destabilizing 0.82 D 0.641 neutral N 0.473563836 None None N
L/S 0.2072 likely_benign 0.2531 benign -2.122 Highly Destabilizing 0.633 D 0.595 neutral None None None None N
L/T 0.1186 likely_benign 0.1479 benign -1.835 Destabilizing 0.775 D 0.537 neutral None None None None N
L/V 0.1083 likely_benign 0.1304 benign -1.043 Destabilizing 0.722 D 0.465 neutral N 0.474938599 None None N
L/W 0.3247 likely_benign 0.4195 ambiguous -1.38 Destabilizing 0.996 D 0.704 prob.neutral None None None None N
L/Y 0.4009 ambiguous 0.5009 ambiguous -1.059 Destabilizing 0.961 D 0.642 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.